P3 Health Partners
PIII
15 hedge funds and large institutions have $2.95M invested in P3 Health Partners in 2025 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 2 closing their positions.
47% more capital invested
Capital invested by funds: $2M → $2.95M (+$950K)
25% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 4
0.32% more ownership
Funds ownership: 9.73% → 10.05% (+0.32%)
6% less funds holding
Funds holding: 16 → 15 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$78.1K |
| 2 |
TFA
Trinity Financial Advisors
Columbus,
Ohio
|
+$8.89K |
| 3 |
William Blair & Company
Chicago,
Illinois
|
+$5.02K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.27K |
| 5 |
Barclays
London,
United Kingdom
|
+$498 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$11.1K |
| 2 |
Morgan Stanley
New York
|
-$2.27K |
| 3 |
BNP Paribas Financial Markets
Paris,
France
|
-$1.28K |
| 4 |
BlackRock
New York
|
-$324 |
| 5 |
Raymond James Financial
St Petersburg,
Florida
|
-$296 |
PIII Hedge Fund Activity: Q3 2025 in Review
15 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in P3 Health Partners (PIII) for Q3 2025, worth a combined $2.95M — up 47% from $2M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of PIII and 1 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 5 added.
The largest buyer was Vanguard Group, adding an estimated $78.1K. The largest seller was UBS Group, cutting an estimated $11.1K.
- 15 institutional investors held P3 Health Partners (PIII) as of Q3 2025, down from 16 in Q2 2025.
- Funds reported $2.95M of P3 Health Partners stock for Q3 2025, up 47% quarter-over-quarter.
- 1 fund opened new P3 Health Partners positions in Q3 2025 and 2 closed out, a net change of -1 holder.
- The largest P3 Health Partners buyer in Q3 2025 was Vanguard Group, an estimated $78.1K added.
- The largest P3 Health Partners seller in Q3 2025 was UBS Group, an estimated $11.1K sold.
Based on aggregated 13F filings for Q3 2025.